Company · CIK 0000874015 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
IONIS PHARMACEUTICALS INC · IONS
Insider activity reported against this company. All insider holders · Files at: AKCA, RGLS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 JForm 4 → | Sep 2, 8:32 pm EDT | C Frank BennettEVP, Chief Scientific Officer | 110 | $51.31 | $5,644 | 60,128 | — | |
| Aug 31, 2026 JForm 4 → | Sep 2, 8:22 pm EDT | Patrick R. O'NeilEVP CLO & General Counsel | 63 | $51.31 | $3,232 | 59,205 | — | |
| Aug 31, 2026 JForm 4 → | Sep 2, 8:22 pm EDT | Brett P MoniaChief Executive Officer, Director | 98 | $51.31 | $5,028 | 242,760 | — | |
| Aug 31, 2026 JForm 4 → | Sep 2, 8:22 pm EDT | Brian BirchlerEVP, Corp and Development Ops | 58 | $51.31 | $2,976 | 102,883 | — | |
| Jul 30, 2026 PForm 4 → | Jul 31, 4:42 pm EDT | Michael R HaydenDirector | 20,000 | $52.94 | $1,058,700 | 24,000 | +500% | |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:12 pm EDT | Joan E HermanDirector | 5,220 | — | — | 51,306 | — | |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:12 pm EDT | Spencer R BerthelsenDirector | 5,220 | — | — | 161,233 | — | |
| Jul 7, 2026 JForm 4 → | Jul 9, 7:26 pm EDT | C Frank BennettEVP, Chief Scientific Officer | 15,000 | — | — | 15,000 | — | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 9, 7:26 pm EDT | C Frank BennettEVP, Chief Scientific Officer | 20,536 | $84.95 | $1,744,623 | 0 | −100% | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 9, 6:07 pm EDT | Allene M. DiazDirector | 10,111 | $85.42 | $863,637 | 3,811 | −72.6% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 9, 6:07 pm EDT | Allene M. DiazDirector | 10,111 | $47.11 | $476,329 | 13,922 | — | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 9, 6:07 pm EDT | Holly B. KordasiewiczEVP, Chief Development Officer | 362 | $84.30 | $30,517 | 22,096 | −1.61% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 6:49 pm EDT | Joseph Klein IIIDirector | 11,518 | $79.04 | $910,416 | 11,014 | −51.1% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 6:49 pm EDT | Joseph Klein IIIDirector | 11,518 | $39.94 | $460,029 | 22,532 | — | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 30, 5:48 pm EDT | Joseph BaroldiEVP, Chief Business Officer | 5,635 | $80.16 | $451,699 | 4,669 | −54.7% | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 5:48 pm EDT | Joseph BaroldiEVP, Chief Business Officer | 5,635 | $49.19 | $277,181 | 10,304 | — | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 30, 5:48 pm EDT | Patrick R. O'NeilEVP CLO & General Counsel | 3,069 | $80.00 | $245,520 | 61,470 | −4.76% | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 30, 5:48 pm EDT | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | 26,000 | $81.05 | $2,107,196 | 77,114 | −25.2% | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 5:48 pm EDT | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | 26,000 | $60.89 | $1,583,140 | 103,114 | — | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 26, 7:09 pm EDT | Eric SwayzeEVP Research | 10,602 | $79.18 | $839,492 | 21,759 | −32.8% | 10b5-1 |
| Jun 24, 2026 SForm 4 → | Jun 26, 7:09 pm EDT | Brett P MoniaChief Executive Officer, Director | 85,637 | $79.70 | $6,825,524 | 245,571 | −25.9% | 10b5-1 |
| Jun 24, 2026 MForm 4 → | Jun 26, 7:09 pm EDT | Brett P MoniaChief Executive Officer, Director | 85,637 | $46.72 | $4,000,766 | 295,571 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 16, 5:26 pm EDT | Spencer R BerthelsenDirector | 8,000 | $73.49 | $587,920 | 156,013 | −4.88% | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 16, 5:26 pm EDT | Spencer R BerthelsenDirector | 8,000 | $24.42 | $195,360 | 164,013 | — | 10b5-1 |
| Jun 12, 2026 SForm 4 → | Jun 16, 5:26 pm EDT | Holly B. KordasiewiczEVP, Chief Development Officer | 60,846 | $73.41 | $4,466,428 | 22,458 | −73.0% | 10b5-1 |
| Jun 12, 2026 MForm 4 → | Jun 16, 5:26 pm EDT | Holly B. KordasiewiczEVP, Chief Development Officer | 60,846 | $53.97 | $3,283,664 | 83,304 | — | 10b5-1 |
| Jun 1, 2026 SForm 4 → | Jun 3, 5:34 pm EDT | Spencer R BerthelsenDirector | 8,000 | $75.67 | $605,360 | 156,013 | −4.88% | 10b5-1 |
| Jun 1, 2026 MForm 4 → | Jun 3, 5:34 pm EDT | Spencer R BerthelsenDirector | 8,000 | $24.42 | $195,360 | 164,013 | — | 10b5-1 |
| Mar 12, 2019 SForm 4 → | Mar 14, 6:24 pm EDT | B Lynne ParshallDirector | 8,334 | $75.00 | $625,050 | 52,677 | −13.7% | plan? |
| Mar 12, 2019 MForm 4 → | Mar 14, 6:24 pm EDT | B Lynne ParshallDirector | 8,334 | $39.87 | $332,277 | 61,011 | — | plan? |
| Feb 27, 2019 SForm 4 → | Mar 1, 5:56 pm EST | B Lynne ParshallDirector | 8,333 | $70.00 | $583,310 | 52,677 | −13.7% | plan? |
| Feb 27, 2019 MForm 4 → | Mar 1, 5:56 pm EST | B Lynne ParshallDirector | 8,333 | $39.87 | $332,237 | 61,010 | — | plan? |
| Feb 27, 2019 SForm 4 → | Mar 1, 5:40 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 26,800 | $68.01 | $1,822,580 | 19,673 | −57.7% | plan? |
| Feb 27, 2019 MForm 4 → | Mar 1, 5:40 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 26,800 | $45.11 | $1,208,952 | 27,673 | — | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 7:31 pm EST | Stanley T CrookeChairman and CEO, Director | 77,000 | $60.77 | $4,679,499 | 69,634 | −52.5% | plan? |
| Feb 25, 2019 MForm 4 → | Feb 27, 7:31 pm EST | Stanley T CrookeChairman and CEO, Director | 77,000 | $39.87 | $3,069,990 | 106,634 | — | plan? |
| Feb 13, 2019 SForm 4 → | Feb 14, 5:57 pm EST | Stanley T CrookeChairman and CEO, Director | 46,904 | $60.09 | $2,818,268 | 5,532 | −89.4% | plan? |
| Feb 13, 2019 MForm 4 → | Feb 14, 5:57 pm EST | Stanley T CrookeChairman and CEO, Director | 46,904 | $38.88 | $1,823,466 | 10,832 | — | plan? |
| Feb 13, 2019 SForm 4 → | Feb 14, 5:51 pm EST | Richard S GearySVP, Development | 999 | $60.00 | $59,940 | 21,442 | −4.45% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 6:01 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 275 | $59.50 | $16,363 | 19,673 | −1.38% | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 6:01 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 275 | $39.87 | $10,964 | 19,948 | — | plan? |
| Feb 1, 2019 SForm 4 → | Feb 5, 6:05 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 19,600 | $59.25 | $1,161,360 | 19,673 | −49.9% | plan? |
| Feb 1, 2019 MForm 4 → | Feb 5, 6:05 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 19,600 | $39.87 | $781,452 | 35,273 | — | plan? |
| Feb 1, 2019 SForm 4 → | Feb 5, 5:59 pm EST | C Frank BennettSVP, Antisense Research | 9,013 | $58.29 | $525,368 | 24,528 | −26.9% | plan? |
| Feb 1, 2019 MForm 4 → | Feb 5, 5:59 pm EST | C Frank BennettSVP, Antisense Research | 9,013 | $14.69 | $132,401 | 33,541 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:39 pm EST | C Frank BennettSVP, Antisense Research | 10,640 | $58.26 | $164,177 | 24,400 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:36 pm EST | Richard S GearySVP, Development | 10,993 | $58.26 | $169,420 | 22,034 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:35 pm EST | Elizabeth L HougenSVP Finance & CFO | 10,733 | $58.26 | $165,575 | 19,823 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:34 pm EST | Brett P MoniaChief Operating Officer | 13,578 | $58.26 | $208,105 | 22,275 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:27 pm EST | Stanley T CrookeChairman and CEO, Director | 46,561 | $58.26 | $793,967 | 5,532 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:24 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 10,557 | $58.26 | $159,283 | 19,607 | — | plan? |
| Jan 15, 2019 FMForm 4 → | Jan 17, 7:19 pm EST | B Lynne ParshallDirector | 26,815 | $58.26 | $358,823 | 52,677 | — | plan? |
| Jan 3, 2019 SForm 4 → | Jan 3, 7:50 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 4,400 | $54.80 | $241,120 | 14,584 | −23.2% | plan? |
| Jan 2, 2019 SForm 4 → | Jan 3, 7:42 pm EST | Brett P MoniaChief Operating Officer | 214 | $53.50 | $11,449 | 15,837 | −1.33% | plan? |
| Jan 1, 2019 JMForm 4 → | Jan 3, 7:50 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 4,466 | $37.22 | $166,214 | 18,584 | — | plan? |
| Jan 1, 2019 JForm 4 → | Jan 3, 7:44 pm EST | Elizabeth L HougenSVP Finance & CFO | 127 | $36.45 | $4,629 | 14,901 | — | plan? |
| Jan 1, 2019 JForm 4 → | Jan 3, 7:42 pm EST | Brett P MoniaChief Operating Officer | 210 | $36.45 | $7,654 | 16,051 | — | plan? |
| Jan 1, 2019 JForm 4 → | Jan 3, 7:34 pm EST | Richard S GearySVP, Development | 407 | $36.45 | $14,834 | 17,264 | — | plan? |
| Jan 1, 2019 JForm 4 → | Jan 3, 7:32 pm EST | C Frank BennettSVP, Antisense Research | 128 | $36.45 | $4,665 | 19,524 | — | plan? |
| Dec 18, 2018 SForm 4 → | Dec 20, 5:55 pm EST | Elizabeth L HougenSVP, Finance & CFO | 4,063 | $52.03 | $211,379 | 14,774 | −21.6% | plan? |
| Dec 18, 2018 MForm 4 → | Dec 20, 5:55 pm EST | Elizabeth L HougenSVP, Finance & CFO | 4,063 | $7.25 | $29,457 | 16,837 | — | plan? |
| Nov 23, 2018 SForm 4 → | Nov 26, 8:01 pm EST | Brett P MoniaChief Operating Officer | 34,000 | $55.00 | $1,870,058 | 15,841 | −68.2% | plan? |
| Nov 23, 2018 MForm 4 → | Nov 26, 8:01 pm EST | Brett P MoniaChief Operating Officer | 34,000 | $14.69 | $499,460 | 49,841 | — | plan? |
| Nov 1, 2018 SForm 4 → | Nov 1, 7:34 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | $49.54 | $619,245 | 19,396 | −39.2% | plan? |
| Nov 1, 2018 MForm 4 → | Nov 1, 7:34 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | $14.69 | $183,625 | 31,896 | — | plan? |
| Aug 27, 2018 SForm 4 → | Aug 29, 4:49 pm EDT | Brett P MoniaChief Operating Officer | 16,493 | $54.00 | $890,622 | 15,841 | −51.0% | plan? |
| Aug 27, 2018 MForm 4 → | Aug 29, 4:49 pm EDT | Brett P MoniaChief Operating Officer | 16,493 | $7.23 | $119,274 | 23,341 | — | plan? |
| Aug 8, 2018 SForm 4 → | Aug 9, 6:34 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | $45.00 | $562,500 | 19,396 | −39.2% | plan? |
| Aug 8, 2018 MForm 4 → | Aug 9, 6:34 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | $14.68 | $183,528 | 31,883 | — | plan? |
| Jul 24, 2018 SForm 4 → | Jul 25, 7:19 pm EDT | Brett P MoniaChief Operating Officer | 156 | $47.03 | $7,337 | 15,841 | −0.98% | plan? |
| Jul 17, 2018 MForm 4 → | Jul 19, 6:45 pm EDT | Joseph H WenderDirector | 30,000 | $9.26 | $277,800 | 68,916 | — | plan? |
| Jul 1, 2018 JForm 4 → | Jul 3, 3:35 pm EDT | C Frank BennettSVP, Antisense Research | 282 | $35.42 | $9,988 | 19,396 | — | plan? |
| Jul 1, 2018 JForm 4 → | Jul 3, 3:33 pm EDT | Richard S GearySVP, Development | 177 | $35.42 | $6,269 | 16,857 | — | plan? |
| Jul 1, 2018 JForm 4 → | Jul 3, 3:31 pm EDT | Elizabeth L HougenSVP Finance & CFO | 274 | $35.42 | $9,705 | 14,774 | — | plan? |
| Jul 1, 2018 JForm 4 → | Jul 3, 3:30 pm EDT | Brett P MoniaChief Operating Officer | 214 | $35.42 | $7,580 | 15,997 | — | plan? |
| Jul 1, 2018 JForm 4 → | Jul 3, 3:28 pm EDT | Patrick R. O'NeilSVP Legal & General Counsel | 66 | $35.42 | $2,338 | 14,518 | — | plan? |
| Jul 1, 2018 MForm 4 → | Jul 3, 3:20 pm EDT | Joseph LoscalzoDirector | 2,667 | — | — | 10,419 | — | plan? |
| Jul 1, 2018 MForm 4 → | Jul 3, 3:13 pm EDT | Breaux CastlemanDirector | 2,667 | — | — | 12,294 | — | plan? |
| Jul 1, 2018 MForm 4/A → | Jul 3, 3:11 pm EDT | Frederick T MutoDirector | 2,667 | — | — | 9,794 | — | plan? |
| Jul 1, 2018 MForm 4 → | Jul 3, 3:10 pm EDT | Joseph H WenderDirector | 2,667 | — | — | 38,916 | — | plan? |
| Jul 1, 2018 MForm 4 → | Jul 3, 3:08 pm EDT | Spencer R BerthelsenDirector | 2,667 | — | — | 94,094 | — | plan? |
| Jul 1, 2018 MForm 4 → | Jul 3, 3:07 pm EDT | Joseph Klein IIIDirector | 2,667 | — | — | 12,606 | — | plan? |
| Jun 25, 2018 SForm 4 → | Jun 25, 8:28 pm EDT | Spencer R BerthelsenDirector | 15,000 | $42.30 | $634,542 | 91,427 | −14.1% | plan? |
| Jun 25, 2018 MForm 4 → | Jun 25, 8:28 pm EDT | Spencer R BerthelsenDirector | 15,000 | $13.88 | $208,200 | 100,727 | — | plan? |
| May 31, 2018 SForm 4 → | May 31, 8:02 pm EDT | Frederick T MutoDirector | 15,000 | $46.45 | $696,750 | 7,127 | −67.8% | plan? |
| May 31, 2018 MForm 4 → | May 31, 8:02 pm EDT | Frederick T MutoDirector | 15,000 | $13.88 | $208,200 | 22,127 | — | plan? |
| May 11, 2018 SForm 4 → | May 11, 9:06 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | $45.00 | $562,500 | 19,114 | −39.5% | plan? |
| May 11, 2018 MForm 4 → | May 11, 9:06 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | $7.25 | $90,625 | 31,614 | — | plan? |
| May 11, 2018 SForm 4 → | May 11, 9:00 pm EDT | Joseph H WenderDirector | 15,000 | $45.31 | $679,614 | 36,249 | −29.3% | plan? |
| May 11, 2018 MForm 4 → | May 11, 9:00 pm EDT | Joseph H WenderDirector | 15,000 | $13.88 | $208,200 | 44,839 | — | plan? |
| Apr 17, 2018 SForm 4 → | Apr 19, 5:22 pm EDT | Stanley T CrookeChairman and CEO, Director | 13,962 | $44.40 | $619,913 | 4,128 | −77.2% | plan? |
| Apr 17, 2018 MForm 4 → | Apr 19, 5:22 pm EDT | Stanley T CrookeChairman and CEO, Director | 13,962 | $13.58 | $189,622 | 6,128 | — | plan? |
| Mar 29, 2018 SForm 4 → | Mar 30, 3:51 pm EDT | Joseph Klein IIIDirector | 2,000 | $46.15 | $92,300 | 9,939 | −16.8% | plan? |
| Mar 29, 2018 MForm 4 → | Mar 30, 3:51 pm EDT | Joseph Klein IIIDirector | 2,000 | $24.42 | $48,840 | 11,939 | — | plan? |
| Mar 15, 2018 SForm 4 → | Mar 16, 4:19 pm EDT | Joseph Klein IIIDirector | 2,000 | $51.13 | $102,258 | 9,939 | −16.8% | plan? |
| Mar 15, 2018 MForm 4 → | Mar 16, 4:19 pm EDT | Joseph Klein IIIDirector | 2,000 | $24.42 | $48,840 | 10,139 | — | plan? |
| Mar 12, 2018 SForm 4 → | Mar 13, 9:14 pm EDT | Patrick R. O'NeilSVP Legal & General Counsel | 1,000 | $55.00 | $55,000 | 14,452 | −6.47% | plan? |
| Mar 12, 2018 MForm 4 → | Mar 13, 9:14 pm EDT | Patrick R. O'NeilSVP Legal & General Counsel | 1,000 | $10.82 | $10,820 | 15,452 | — | plan? |
| Feb 28, 2018 SForm 4 → | Mar 1, 5:52 pm EST | Joseph Klein IIIDirector | 3,000 | $51.91 | $155,727 | 9,939 | −23.2% | plan? |
| Feb 28, 2018 MForm 4 → | Mar 1, 5:52 pm EST | Joseph Klein IIIDirector | 3,000 | $35.53 | $106,590 | 12,039 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 AForm 4 → | Jul 17, 5:13 pm EDT | Peter N ReikesDirector | 3,399 | — | — | 3,399 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 5:13 pm EDT | Ludwig HantsonDirector | 3,399 | — | — | 3,399 | — | |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:12 pm EDT | Joan E HermanDirector | 5,220 | — | — | 2,301 | — | |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:12 pm EDT | Spencer R BerthelsenDirector | 5,220 | — | — | 2,301 | — | |
| Jul 7, 2026 JForm 4 → | Jul 9, 7:26 pm EDT | C Frank BennettEVP, Chief Scientific Officer | 15,000 | — | — | 12,109 | — | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 9, 6:07 pm EDT | Allene M. DiazDirector | 10,111 | — | — | 0 | — | 10b5-1 |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:50 pm EDT | Michael J. YangDirector | 7,670 | — | — | 9,451 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:50 pm EDT | Joseph LoscalzoDirector | 7,670 | — | — | 7,521 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:49 pm EDT | Joan E HermanDirector | 7,670 | — | — | 7,521 | — | |
| Jul 1, 2026 AMForm 4 → | Jul 6, 6:49 pm EDT | Joseph Klein IIIDirector | 19,188 | — | — | 16,277 | — | 10b5-1 |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:45 pm EDT | Michael R HaydenDirector | 7,670 | — | — | 12,198 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:44 pm EDT | Allene M. DiazDirector | 7,670 | — | — | 7,521 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:44 pm EDT | Spencer R BerthelsenDirector | 7,670 | — | — | 7,521 | — | |
| Jun 26, 2026 MForm 4 → | Jun 30, 5:48 pm EDT | Joseph BaroldiEVP, Chief Business Officer | 5,635 | — | — | 0 | — | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 5:48 pm EDT | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | 26,000 | — | — | 26,000 | — | 10b5-1 |
| Jun 24, 2026 MForm 4 → | Jun 26, 7:09 pm EDT | Brett P MoniaChief Executive Officer, Director | 85,637 | — | — | 99,872 | — | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 16, 5:26 pm EDT | Spencer R BerthelsenDirector | 8,000 | — | — | 0 | — | 10b5-1 |
| Jun 12, 2026 MForm 4 → | Jun 16, 5:26 pm EDT | Holly B. KordasiewiczEVP, Chief Development Officer | 60,846 | — | — | 0 | — | 10b5-1 |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:59 pm EDT | Peter N ReikesDirector | 10,753 | — | — | 10,753 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:59 pm EDT | Ludwig HantsonDirector | 10,753 | — | — | 10,753 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 5:34 pm EDT | Spencer R BerthelsenDirector | 8,000 | — | — | 8,000 | — | 10b5-1 |
| Mar 12, 2019 MForm 4 → | Mar 14, 6:24 pm EDT | B Lynne ParshallDirector | 8,334 | — | — | 57,500 | — | |
| Feb 27, 2019 MForm 4 → | Mar 1, 5:56 pm EST | B Lynne ParshallDirector | 8,333 | — | — | 65,834 | — | |
| Feb 27, 2019 MForm 4 → | Mar 1, 5:40 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 26,800 | — | — | 0 | — | |
| Feb 25, 2019 MForm 4 → | Feb 27, 7:31 pm EST | Stanley T CrookeChairman and CEO, Director | 77,000 | — | — | 70,500 | — | |
| Feb 13, 2019 MForm 4 → | Feb 14, 5:57 pm EST | Stanley T CrookeChairman and CEO, Director | 46,904 | — | — | 3,200 | — | |
| Feb 12, 2019 MForm 4 → | Feb 14, 6:01 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 275 | — | — | 8,000 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 6:05 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 19,600 | — | — | 8,275 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 5:59 pm EST | C Frank BennettSVP, Antisense Research | 9,013 | — | — | 0 | — | |
| Jan 15, 2019 AMForm 4 → | Jan 17, 7:39 pm EST | C Frank BennettSVP, Antisense Research | 28,619 | — | — | 14,463 | — | |
| Jan 15, 2019 AMForm 4 → | Jan 17, 7:36 pm EST | Richard S GearySVP, Development | 33,815 | — | — | 15,048 | — | |
| Jan 15, 2019 AMForm 4 → | Jan 17, 7:35 pm EST | Elizabeth L HougenSVP Finance & CFO | 30,022 | — | — | 14,463 | — | |
| Jan 15, 2019 AMForm 4 → | Jan 17, 7:34 pm EST | Brett P MoniaChief Operating Officer | 55,734 | — | — | 20,280 | — | |
| Jan 15, 2019 AMForm 4 → | Jan 17, 7:27 pm EST | Stanley T CrookeChairman and CEO, Director | 101,991 | — | — | 4,612 | — | |
| Jan 15, 2019 AMForm 4 → | Jan 17, 7:24 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 29,954 | — | — | 14,466 | — | |
| Jan 15, 2019 AForm 4 → | Jan 17, 7:23 pm EST | Damien McDevittChief Business Officer | 13,065 | — | — | 13,065 | — | |
| Jan 15, 2019 MForm 4 → | Jan 17, 7:19 pm EST | B Lynne ParshallDirector | 20,656 | — | — | 35,100 | — | |
| Jan 2, 2019 AMForm 4 → | Jan 3, 7:50 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 54,200 | — | — | 27,875 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 7:46 pm EST | Damien McDevittChief Business Officer | 29,400 | — | — | 29,400 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 7:44 pm EST | Elizabeth L HougenSVP Finance & CFO | 49,800 | — | — | 49,800 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 7:42 pm EST | Brett P MoniaChief Operating Officer | 102,900 | — | — | 102,900 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 7:34 pm EST | Richard S GearySVP, Development | 57,900 | — | — | 57,900 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 7:32 pm EST | C Frank BennettSVP, Antisense Research | 46,800 | — | — | 46,800 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 7:29 pm EST | Stanley T CrookeChairman and CEO, Director | 155,400 | — | — | 12,000 | — | |
| Dec 18, 2018 MForm 4 → | Dec 20, 5:55 pm EST | Elizabeth L HougenSVP, Finance & CFO | 4,063 | — | — | 0 | — | |
| Nov 23, 2018 MForm 4 → | Nov 26, 8:01 pm EST | Brett P MoniaChief Operating Officer | 34,000 | — | — | 0 | — | |
| Nov 1, 2018 MForm 4 → | Nov 1, 7:34 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | — | — | 9,013 | — | |
| Oct 15, 2018 AForm 4 → | Oct 15, 8:55 pm EDT | Peter N ReikesDirector | 7,110 | — | — | 7,110 | — | |
| Oct 15, 2018 AForm 4 → | Oct 15, 8:51 pm EDT | Michael R HaydenDirector | 7,110 | — | — | 7,110 | — | |
| Sep 23, 2018 AForm 4 → | Sep 24, 8:04 pm EDT | Peter N ReikesDirector | 32,000 | — | — | 32,000 | — | |
| Sep 20, 2018 AForm 4 → | Sep 24, 8:14 pm EDT | Michael R HaydenDirector | 32,000 | — | — | 32,000 | — | |
| Aug 27, 2018 MForm 4 → | Aug 29, 4:49 pm EDT | Brett P MoniaChief Operating Officer | 16,493 | — | — | 0 | — | |
| Aug 8, 2018 MForm 4 → | Aug 9, 6:34 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | — | — | 21,513 | — | |
| Jul 17, 2018 MForm 4 → | Jul 19, 6:45 pm EDT | Joseph H WenderDirector | 30,000 | — | — | 0 | — | |
| Jul 15, 2018 AForm 4 → | Jul 16, 6:58 pm EDT | Damien McDevittChief Business Officer | 14,167 | — | — | 14,167 | — | |
| Jul 2, 2018 AForm 4 → | Jul 3, 3:18 pm EDT | B Lynne ParshallDirector | 19,555 | — | — | 16,000 | — | |
| Jul 1, 2018 AMForm 4 → | Jul 3, 3:20 pm EDT | Joseph LoscalzoDirector | 22,222 | — | — | 16,000 | — | |
| Jul 1, 2018 AMForm 4 → | Jul 3, 3:13 pm EDT | Breaux CastlemanDirector | 22,222 | — | — | 16,000 | — | |
| Jul 1, 2018 AMForm 4/A → | Jul 3, 3:11 pm EDT | Frederick T MutoDirector | 22,222 | — | — | 16,000 | — | |
| Jul 1, 2018 AMForm 4 → | Jul 3, 3:10 pm EDT | Joseph H WenderDirector | 22,222 | — | — | 16,000 | — | |
| Jul 1, 2018 AMForm 4 → | Jul 3, 3:08 pm EDT | Spencer R BerthelsenDirector | 22,222 | — | — | 16,000 | — | |
| Jul 1, 2018 AMForm 4 → | Jul 3, 3:07 pm EDT | Joseph Klein IIIDirector | 22,222 | — | — | 16,000 | — | |
| Jun 25, 2018 MForm 4 → | Jun 25, 8:28 pm EDT | Spencer R BerthelsenDirector | 15,000 | — | — | 0 | — | |
| Jun 18, 2018 AForm 4 → | Jun 18, 6:33 pm EDT | Damien McDevittChief Business Officer | 63,750 | — | — | 63,750 | — | |
| May 31, 2018 MForm 4 → | May 31, 8:02 pm EDT | Frederick T MutoDirector | 15,000 | — | — | 0 | — | |
| May 11, 2018 MForm 4 → | May 11, 9:06 pm EDT | C Frank BennettSVP, Antisense Research | 12,500 | — | — | 13 | — | |
| May 11, 2018 MForm 4 → | May 11, 9:00 pm EDT | Joseph H WenderDirector | 15,000 | — | — | 0 | — | |
| Apr 17, 2018 MForm 4 → | Apr 19, 5:22 pm EDT | Stanley T CrookeChairman and CEO, Director | 13,962 | — | — | 2,904 | — | |
| Mar 29, 2018 MForm 4 → | Mar 30, 3:51 pm EDT | Joseph Klein IIIDirector | 2,000 | — | — | 0 | — | |
| Mar 15, 2018 MForm 4 → | Mar 16, 4:19 pm EDT | Joseph Klein IIIDirector | 2,000 | — | — | 2,000 | — | |
| Mar 12, 2018 MForm 4 → | Mar 13, 9:14 pm EDT | Patrick R. O'NeilSVP Legal & General Counsel | 1,000 | — | — | 400 | — | |
| Feb 28, 2018 MForm 4 → | Mar 1, 5:52 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 0 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 6:00 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 3,000 | — | |
| Feb 3, 2018 MForm 4/A → | Feb 5, 9:06 pm EST | Joseph LoscalzoDirector | 937 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4/A → | Feb 1, 7:58 pm EST | C Frank BennettSVP, Antisense Research | 12,500 | — | — | 12,513 | — | |
| Jan 30, 2018 MForm 4/A → | Jan 31, 4:18 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 6,000 | — | |
| Jan 29, 2018 MForm 4 → | Jan 31, 4:16 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 355 | — | — | 1,400 | — | |
| Jan 29, 2018 MForm 4/A → | Jan 31, 4:15 pm EST | Stanley T CrookeChairman and CEO, Director | 11,000 | — | — | 6,904 | — | |
| Jan 25, 2018 MForm 4 → | Jan 29, 4:08 pm EST | Patrick R. O'NeilSVP Legal & General Counsel | 645 | — | — | 55 | — | |
| Jan 16, 2018 MForm 4 → | Jan 17, 9:28 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 9,000 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:46 pm EST | Elizabeth L HougenSVP, Finance & CFO | 18,869 | — | — | 10,217 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:26 pm EST | Richard S GearySVP, Development | 19,648 | — | — | 10,217 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:25 pm EST | B Lynne ParshallDirector | 41,355 | — | — | 29,185 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:25 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 18,804 | — | — | 10,148 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:23 pm EST | Sarah BoyceChief Business Officer | 18,283 | — | — | 10,427 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:22 pm EST | C Frank BennettSVP, Antisense Research | 18,800 | — | — | 10,148 | — | |
| Jan 15, 2018 AMForm 4 → | Jan 17, 9:22 pm EST | Stanley T CrookeChairman and CEO, Director | 70,394 | — | — | 3,047 | — | |
| Jan 14, 2018 AMForm 4 → | Jan 17, 9:21 pm EST | Brett P MoniaCOO | 56,568 | — | — | 10,703 | — | |
| Jan 8, 2018 MForm 4 → | Jan 10, 6:43 pm EST | Stanley T CrookeChairman and CEO, Director | 11,000 | — | — | 7,904 | — | |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:41 pm EST | Stanley T CrookeChairman and CEO, Director | 22,000 | — | — | 8,904 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:51 pm EST | B Lynne ParshallCOO, Director | 103,575 | — | — | 103,575 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:50 pm EST | Patrick R. O'NeilSVP, Legal & General Counsel | 54,638 | — | — | 54,638 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:49 pm EST | Brett P MoniaSVP, Antisense Drug Discovery | 58,125 | — | — | 58,125 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:49 pm EST | Elizabeth L HougenSVP, Finance & CFO | 54,619 | — | — | 54,619 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:48 pm EST | Richard S GearySVP, Development | 58,125 | — | — | 58,125 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:46 pm EST | Stanley T CrookeChairman and CEO, Director | 175,778 | — | — | 17,603 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:45 pm EST | Sarah BoyceChief Business Officer | 58,125 | — | — | 58,125 | — | |
| Jan 2, 2018 AForm 4 → | Jan 2, 8:45 pm EST | C Frank BennettSVP, Antisense Research | 54,619 | — | — | 54,619 | — | |
| Dec 29, 2017 MForm 4 → | Jan 2, 2018, 5:50 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 0 | — | |
| Dec 15, 2017 MForm 4 → | Dec 19, 8:27 pm EST | Joseph Klein IIIDirector | 3,000 | — | — | 3,000 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2018 JForm 4 → | Oct 18, 8:05 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 1,671,849 | — | — | 67,383,965 | — | plan? |
| Aug 3, 2018 JForm 4 → | Aug 6, 5:17 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 1,597,571 | — | — | 65,712,116 | — | plan? |
| Apr 17, 2018 PForm 4 → | Apr 19, 6:48 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 10,666,666 | $18.75 | $199,999,988 | 64,114,545 | +20.0% | plan? |
| Apr 17, 2018 JForm 4 → | Apr 19, 6:48 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 8,000,000 | — | — | 53,447,879 | — | plan? |
| Jul 19, 2017 PForm 4 → | Jul 21, 4:04 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 3,125,000 | $8.00 | $25,000,000 | 45,447,879 | +7.38% | plan? |
| Jul 19, 2017 CJForm 4 → | Jul 21, 4:04 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 42,322,879 | — | — | 42,322,879 | — | plan? |
| Jul 15, 2015 SForm 4 → | Jul 17, 6:08 pm EDT | Regulus Therapeutics Inc.RGLS | 343,133 | $10.60 | $3,636,078 | 5,173,172 | −6.22% | plan? |
| Jun 30, 2015 SForm 4 → | Jul 2, 4:28 pm EDT | Regulus Therapeutics Inc.RGLS | 13,248 | $10.79 | $143,010 | 5,516,305 | −0.24% | plan? |
| Jun 23, 2015 GForm 4 → | Jul 2, 4:28 pm EDT | Regulus Therapeutics Inc.RGLS | 13,248 | — | — | 5,529,553 | — | plan? late |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2017 CForm 4 → | Jul 21, 4:04 pm EDT | AKCEA THERAPEUTICS, INC.AKCA | 28,884,540 | — | — | 0 | — |